Vivos Therapeutics Inc — Cash Flow (NASDAQ:VVOS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 5.68 M15.7 M19.6 M11.9 M12.7 M 14.4 M Cash from investing activities 120.25 K2.61 M924 K853 K568 K 6.11 M Cash from financing activities 23.54 M24.17 M010.92 M17.88 M 17.28 M Free cash flow 5.56 M13.3 M18.68 M11.1 M12.13 M 13.43 M

News

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics announces $4.64 million warrant exercise deal

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript

Vivos opens new sleep center in Michigan, expanding national footprint

Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript

Earnings call transcript: Vivos Therapeutics Q3 2025 shows revenue growth

Vivos earnings missed by $0.01, revenue topped estimates

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)

ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates

Aclaris Therapeutics (ACRS) Reports Q3 Loss, Tops Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript